Zydus Lifesciences informs about press release

04 May 2024 Evaluate

Zydus Lifesciences has informed that it enclosed a copy of press release dated May 4, 2024 titled ‘Sentynl Therapeutics announces global acquisition of Zokinvy® (Lonafarnib) for treatment of Hutchinson-Gilford Progeria Syndrome from Eiger Biopharmaceuticals’.

The above information is a part of company’s filings submitted to BSE.

Zydus Lifesciences Share Price

1076.45 -12.00 (-1.10%)
22-May-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1540.30
Dr. Reddys Lab 5872.65
Cipla 1481.55
Zydus Lifesciences 1076.45
Lupin 1712.05
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.